Publikationen in Zusammenarbeit mit Forschern von Stanford University School of Medicine (5)

2021

  1. Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31

2017

  1. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    The Lancet, Vol. 390, Núm. 10094, pp. 555-566

  2. Global position paper on cardiovascular regenerative medicine

    European Heart Journal

2011

  1. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas

    Leukemia, Vol. 25, Núm. 12, pp. 1882-1890

2010

  1. Clinical applications of reporter gene technology

    Molecular Imaging with Reporter Genes (Cambridge University Press), pp. 297-314